nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—Chills—Irinotecan—stomach cancer	0.00307	0.00431	CcSEcCtD
Midodrine—Dry skin—Capecitabine—stomach cancer	0.00303	0.00426	CcSEcCtD
Midodrine—Flatulence—Irinotecan—stomach cancer	0.00293	0.00412	CcSEcCtD
Midodrine—Cramps of lower extremities—Epirubicin—stomach cancer	0.00292	0.00409	CcSEcCtD
Midodrine—Back pain—Irinotecan—stomach cancer	0.00288	0.00404	CcSEcCtD
Midodrine—Muscle spasms—Irinotecan—stomach cancer	0.00286	0.00402	CcSEcCtD
Midodrine—Abdominal discomfort—Capecitabine—stomach cancer	0.00274	0.00385	CcSEcCtD
Midodrine—Cramps of lower extremities—Doxorubicin—stomach cancer	0.0027	0.00379	CcSEcCtD
Midodrine—Dysuria—Capecitabine—stomach cancer	0.00267	0.00375	CcSEcCtD
Midodrine—Hepatic function abnormal—Epirubicin—stomach cancer	0.00264	0.0037	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.00261	0.00366	CcSEcCtD
Midodrine—Hypertension—Irinotecan—stomach cancer	0.00257	0.00361	CcSEcCtD
Midodrine—Stomatitis—Docetaxel—stomach cancer	0.00257	0.0036	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.00253	0.00355	CcSEcCtD
Midodrine—Hepatobiliary disease—Docetaxel—stomach cancer	0.00249	0.0035	CcSEcCtD
Midodrine—Stomatitis—Capecitabine—stomach cancer	0.00248	0.00349	CcSEcCtD
Midodrine—Confusional state—Irinotecan—stomach cancer	0.00245	0.00344	CcSEcCtD
Midodrine—Hepatic function abnormal—Doxorubicin—stomach cancer	0.00244	0.00342	CcSEcCtD
Midodrine—Hepatobiliary disease—Capecitabine—stomach cancer	0.00241	0.00338	CcSEcCtD
Midodrine—Nervous system disorder—Irinotecan—stomach cancer	0.00238	0.00334	CcSEcCtD
Midodrine—Irritability—Methotrexate—stomach cancer	0.00235	0.0033	CcSEcCtD
Midodrine—Confusional state—Fluorouracil—stomach cancer	0.00235	0.00329	CcSEcCtD
Midodrine—Urinary tract disorder—Docetaxel—stomach cancer	0.00233	0.00328	CcSEcCtD
Midodrine—Bradycardia—Capecitabine—stomach cancer	0.00233	0.00327	CcSEcCtD
Midodrine—Urethral disorder—Docetaxel—stomach cancer	0.00232	0.00325	CcSEcCtD
Midodrine—Nervous system disorder—Fluorouracil—stomach cancer	0.00228	0.0032	CcSEcCtD
Midodrine—Tachycardia—Fluorouracil—stomach cancer	0.00227	0.00319	CcSEcCtD
Midodrine—Urinary tract disorder—Capecitabine—stomach cancer	0.00226	0.00317	CcSEcCtD
Midodrine—Urethral disorder—Capecitabine—stomach cancer	0.00224	0.00315	CcSEcCtD
Midodrine—Erythema multiforme—Docetaxel—stomach cancer	0.00223	0.00314	CcSEcCtD
Midodrine—Insomnia—Irinotecan—stomach cancer	0.0022	0.00308	CcSEcCtD
Midodrine—Cardiac disorder—Docetaxel—stomach cancer	0.00219	0.00308	CcSEcCtD
Midodrine—Flushing—Docetaxel—stomach cancer	0.00219	0.00308	CcSEcCtD
Midodrine—Paraesthesia—Irinotecan—stomach cancer	0.00218	0.00306	CcSEcCtD
Midodrine—Dyspnoea—Irinotecan—stomach cancer	0.00217	0.00304	CcSEcCtD
Midodrine—Erythema multiforme—Capecitabine—stomach cancer	0.00216	0.00304	CcSEcCtD
Midodrine—Somnolence—Irinotecan—stomach cancer	0.00216	0.00303	CcSEcCtD
Midodrine—Angiopathy—Docetaxel—stomach cancer	0.00214	0.00301	CcSEcCtD
Midodrine—Dyspepsia—Irinotecan—stomach cancer	0.00214	0.003	CcSEcCtD
Midodrine—Flushing—Capecitabine—stomach cancer	0.00212	0.00298	CcSEcCtD
Midodrine—Cardiac disorder—Capecitabine—stomach cancer	0.00212	0.00298	CcSEcCtD
Midodrine—Chills—Docetaxel—stomach cancer	0.00212	0.00298	CcSEcCtD
Midodrine—Dry skin—Epirubicin—stomach cancer	0.00211	0.00296	CcSEcCtD
Midodrine—Insomnia—Fluorouracil—stomach cancer	0.0021	0.00295	CcSEcCtD
Midodrine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.0021	0.00294	CcSEcCtD
Midodrine—Paraesthesia—Fluorouracil—stomach cancer	0.00209	0.00293	CcSEcCtD
Midodrine—Pain—Irinotecan—stomach cancer	0.00208	0.00292	CcSEcCtD
Midodrine—Angiopathy—Capecitabine—stomach cancer	0.00208	0.00291	CcSEcCtD
Midodrine—Dyspnoea—Fluorouracil—stomach cancer	0.00207	0.00291	CcSEcCtD
Midodrine—Mental disorder—Docetaxel—stomach cancer	0.00207	0.00291	CcSEcCtD
Midodrine—Somnolence—Fluorouracil—stomach cancer	0.00207	0.0029	CcSEcCtD
Midodrine—Chills—Capecitabine—stomach cancer	0.00205	0.00288	CcSEcCtD
Midodrine—Dyspepsia—Fluorouracil—stomach cancer	0.00205	0.00287	CcSEcCtD
Midodrine—Abdominal discomfort—Methotrexate—stomach cancer	0.00204	0.00286	CcSEcCtD
Midodrine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00201	0.00282	CcSEcCtD
Midodrine—Mental disorder—Capecitabine—stomach cancer	0.002	0.00281	CcSEcCtD
Midodrine—Feeling abnormal—Irinotecan—stomach cancer	0.002	0.00281	CcSEcCtD
Midodrine—Back pain—Docetaxel—stomach cancer	0.00199	0.00279	CcSEcCtD
Midodrine—Dysuria—Methotrexate—stomach cancer	0.00199	0.00279	CcSEcCtD
Midodrine—Pain—Fluorouracil—stomach cancer	0.00199	0.00279	CcSEcCtD
Midodrine—Gastrointestinal pain—Irinotecan—stomach cancer	0.00199	0.00279	CcSEcCtD
Midodrine—Muscle spasms—Docetaxel—stomach cancer	0.00198	0.00278	CcSEcCtD
Midodrine—Flatulence—Capecitabine—stomach cancer	0.00196	0.00276	CcSEcCtD
Midodrine—Dry skin—Doxorubicin—stomach cancer	0.00195	0.00274	CcSEcCtD
Midodrine—Back pain—Capecitabine—stomach cancer	0.00193	0.0027	CcSEcCtD
Midodrine—Abdominal pain—Irinotecan—stomach cancer	0.00192	0.0027	CcSEcCtD
Midodrine—Feeling abnormal—Fluorouracil—stomach cancer	0.00192	0.00269	CcSEcCtD
Midodrine—Muscle spasms—Capecitabine—stomach cancer	0.00191	0.00269	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.00188	0.00264	CcSEcCtD
Midodrine—Dysuria—Epirubicin—stomach cancer	0.00186	0.00261	CcSEcCtD
Midodrine—Stomatitis—Methotrexate—stomach cancer	0.00185	0.0026	CcSEcCtD
Midodrine—Pollakiuria—Epirubicin—stomach cancer	0.00184	0.00258	CcSEcCtD
Midodrine—Hepatobiliary disease—Methotrexate—stomach cancer	0.00179	0.00252	CcSEcCtD
Midodrine—Hypertension—Docetaxel—stomach cancer	0.00178	0.00249	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.00176	0.00247	CcSEcCtD
Midodrine—Asthenia—Irinotecan—stomach cancer	0.00174	0.00245	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00174	0.00244	CcSEcCtD
Midodrine—Stomatitis—Epirubicin—stomach cancer	0.00173	0.00243	CcSEcCtD
Midodrine—Dysuria—Doxorubicin—stomach cancer	0.00172	0.00242	CcSEcCtD
Midodrine—Hypertension—Capecitabine—stomach cancer	0.00172	0.00241	CcSEcCtD
Midodrine—Dry mouth—Docetaxel—stomach cancer	0.00171	0.0024	CcSEcCtD
Midodrine—Pollakiuria—Doxorubicin—stomach cancer	0.0017	0.00239	CcSEcCtD
Midodrine—Confusional state—Docetaxel—stomach cancer	0.00169	0.00238	CcSEcCtD
Midodrine—Anxiety—Capecitabine—stomach cancer	0.00169	0.00237	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00168	0.00236	CcSEcCtD
Midodrine—Urinary tract disorder—Methotrexate—stomach cancer	0.00168	0.00236	CcSEcCtD
Midodrine—Hepatobiliary disease—Epirubicin—stomach cancer	0.00168	0.00236	CcSEcCtD
Midodrine—Urethral disorder—Methotrexate—stomach cancer	0.00167	0.00234	CcSEcCtD
Midodrine—Dry mouth—Capecitabine—stomach cancer	0.00166	0.00233	CcSEcCtD
Midodrine—Nervous system disorder—Docetaxel—stomach cancer	0.00165	0.00231	CcSEcCtD
Midodrine—Pruritus—Fluorouracil—stomach cancer	0.00165	0.00231	CcSEcCtD
Midodrine—Confusional state—Capecitabine—stomach cancer	0.00164	0.0023	CcSEcCtD
Midodrine—Tachycardia—Docetaxel—stomach cancer	0.00164	0.0023	CcSEcCtD
Midodrine—Skin disorder—Docetaxel—stomach cancer	0.00163	0.00229	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.00163	0.00229	CcSEcCtD
Midodrine—Bradycardia—Epirubicin—stomach cancer	0.00162	0.00228	CcSEcCtD
Midodrine—Erythema multiforme—Methotrexate—stomach cancer	0.00161	0.00226	CcSEcCtD
Midodrine—Dizziness—Irinotecan—stomach cancer	0.00161	0.00225	CcSEcCtD
Midodrine—Stomatitis—Doxorubicin—stomach cancer	0.0016	0.00225	CcSEcCtD
Midodrine—Nervous system disorder—Capecitabine—stomach cancer	0.00159	0.00224	CcSEcCtD
Midodrine—Tachycardia—Capecitabine—stomach cancer	0.00159	0.00223	CcSEcCtD
Midodrine—Cardiac disorder—Methotrexate—stomach cancer	0.00158	0.00222	CcSEcCtD
Midodrine—Skin disorder—Capecitabine—stomach cancer	0.00158	0.00222	CcSEcCtD
Midodrine—Urinary tract disorder—Epirubicin—stomach cancer	0.00157	0.00221	CcSEcCtD
Midodrine—Urethral disorder—Epirubicin—stomach cancer	0.00156	0.00219	CcSEcCtD
Midodrine—Hepatobiliary disease—Doxorubicin—stomach cancer	0.00155	0.00218	CcSEcCtD
Midodrine—Angiopathy—Methotrexate—stomach cancer	0.00155	0.00217	CcSEcCtD
Midodrine—Dizziness—Fluorouracil—stomach cancer	0.00154	0.00216	CcSEcCtD
Midodrine—Rash—Irinotecan—stomach cancer	0.00153	0.00215	CcSEcCtD
Midodrine—Dermatitis—Irinotecan—stomach cancer	0.00153	0.00215	CcSEcCtD
Midodrine—Chills—Methotrexate—stomach cancer	0.00153	0.00215	CcSEcCtD
Midodrine—Headache—Irinotecan—stomach cancer	0.00152	0.00214	CcSEcCtD
Midodrine—Insomnia—Docetaxel—stomach cancer	0.00152	0.00213	CcSEcCtD
Midodrine—Paraesthesia—Docetaxel—stomach cancer	0.00151	0.00212	CcSEcCtD
Midodrine—Erythema multiforme—Epirubicin—stomach cancer	0.00151	0.00212	CcSEcCtD
Midodrine—Bradycardia—Doxorubicin—stomach cancer	0.0015	0.00211	CcSEcCtD
Midodrine—Dyspnoea—Docetaxel—stomach cancer	0.0015	0.0021	CcSEcCtD
Midodrine—Somnolence—Docetaxel—stomach cancer	0.00149	0.0021	CcSEcCtD
Midodrine—Mental disorder—Methotrexate—stomach cancer	0.00149	0.00209	CcSEcCtD
Midodrine—Cardiac disorder—Epirubicin—stomach cancer	0.00148	0.00208	CcSEcCtD
Midodrine—Flushing—Epirubicin—stomach cancer	0.00148	0.00208	CcSEcCtD
Midodrine—Dyspepsia—Docetaxel—stomach cancer	0.00148	0.00207	CcSEcCtD
Midodrine—Insomnia—Capecitabine—stomach cancer	0.00147	0.00206	CcSEcCtD
Midodrine—Rash—Fluorouracil—stomach cancer	0.00147	0.00206	CcSEcCtD
Midodrine—Dermatitis—Fluorouracil—stomach cancer	0.00147	0.00206	CcSEcCtD
Midodrine—Paraesthesia—Capecitabine—stomach cancer	0.00146	0.00205	CcSEcCtD
Midodrine—Headache—Fluorouracil—stomach cancer	0.00146	0.00205	CcSEcCtD
Midodrine—Urinary tract disorder—Doxorubicin—stomach cancer	0.00146	0.00204	CcSEcCtD
Midodrine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00145	0.00203	CcSEcCtD
Midodrine—Dyspnoea—Capecitabine—stomach cancer	0.00145	0.00203	CcSEcCtD
Midodrine—Angiopathy—Epirubicin—stomach cancer	0.00145	0.00203	CcSEcCtD
Midodrine—Urethral disorder—Doxorubicin—stomach cancer	0.00145	0.00203	CcSEcCtD
Midodrine—Nausea—Irinotecan—stomach cancer	0.00144	0.00203	CcSEcCtD
Midodrine—Pain—Docetaxel—stomach cancer	0.00144	0.00202	CcSEcCtD
Midodrine—Back pain—Methotrexate—stomach cancer	0.00143	0.00201	CcSEcCtD
Midodrine—Dyspepsia—Capecitabine—stomach cancer	0.00143	0.00201	CcSEcCtD
Midodrine—Chills—Epirubicin—stomach cancer	0.00143	0.00201	CcSEcCtD
Midodrine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.0014	0.00197	CcSEcCtD
Midodrine—Mental disorder—Epirubicin—stomach cancer	0.0014	0.00196	CcSEcCtD
Midodrine—Erythema multiforme—Doxorubicin—stomach cancer	0.00139	0.00196	CcSEcCtD
Midodrine—Pain—Capecitabine—stomach cancer	0.00139	0.00195	CcSEcCtD
Midodrine—Feeling abnormal—Docetaxel—stomach cancer	0.00138	0.00194	CcSEcCtD
Midodrine—Nausea—Fluorouracil—stomach cancer	0.00138	0.00194	CcSEcCtD
Midodrine—Gastrointestinal pain—Docetaxel—stomach cancer	0.00137	0.00193	CcSEcCtD
Midodrine—Cardiac disorder—Doxorubicin—stomach cancer	0.00137	0.00192	CcSEcCtD
Midodrine—Flushing—Doxorubicin—stomach cancer	0.00137	0.00192	CcSEcCtD
Midodrine—Flatulence—Epirubicin—stomach cancer	0.00137	0.00192	CcSEcCtD
Midodrine—Tension—Epirubicin—stomach cancer	0.00136	0.00191	CcSEcCtD
Midodrine—Nervousness—Epirubicin—stomach cancer	0.00135	0.00189	CcSEcCtD
Midodrine—Back pain—Epirubicin—stomach cancer	0.00134	0.00188	CcSEcCtD
Midodrine—Feeling abnormal—Capecitabine—stomach cancer	0.00134	0.00188	CcSEcCtD
Midodrine—Angiopathy—Doxorubicin—stomach cancer	0.00134	0.00188	CcSEcCtD
Midodrine—Muscle spasms—Epirubicin—stomach cancer	0.00133	0.00187	CcSEcCtD
Midodrine—Gastrointestinal pain—Capecitabine—stomach cancer	0.00133	0.00187	CcSEcCtD
Midodrine—Abdominal pain—Docetaxel—stomach cancer	0.00133	0.00186	CcSEcCtD
Midodrine—Chills—Doxorubicin—stomach cancer	0.00132	0.00186	CcSEcCtD
Midodrine—Mental disorder—Doxorubicin—stomach cancer	0.00129	0.00181	CcSEcCtD
Midodrine—Abdominal pain—Capecitabine—stomach cancer	0.00129	0.0018	CcSEcCtD
Midodrine—Agitation—Epirubicin—stomach cancer	0.00128	0.00179	CcSEcCtD
Midodrine—Flatulence—Doxorubicin—stomach cancer	0.00127	0.00178	CcSEcCtD
Midodrine—Tension—Doxorubicin—stomach cancer	0.00126	0.00177	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00125	0.00176	CcSEcCtD
Midodrine—Nervousness—Doxorubicin—stomach cancer	0.00125	0.00175	CcSEcCtD
Midodrine—Back pain—Doxorubicin—stomach cancer	0.00124	0.00174	CcSEcCtD
Midodrine—Muscle spasms—Doxorubicin—stomach cancer	0.00123	0.00173	CcSEcCtD
Midodrine—Confusional state—Methotrexate—stomach cancer	0.00122	0.00171	CcSEcCtD
Midodrine—Asthenia—Docetaxel—stomach cancer	0.0012	0.00169	CcSEcCtD
Midodrine—Hypertension—Epirubicin—stomach cancer	0.0012	0.00168	CcSEcCtD
Midodrine—Pruritus—Docetaxel—stomach cancer	0.00119	0.00167	CcSEcCtD
Midodrine—Nervous system disorder—Methotrexate—stomach cancer	0.00119	0.00167	CcSEcCtD
Midodrine—Agitation—Doxorubicin—stomach cancer	0.00118	0.00166	CcSEcCtD
Midodrine—Anxiety—Epirubicin—stomach cancer	0.00118	0.00165	CcSEcCtD
Midodrine—Skin disorder—Methotrexate—stomach cancer	0.00118	0.00165	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00117	0.00165	CcSEcCtD
Midodrine—Asthenia—Capecitabine—stomach cancer	0.00117	0.00164	CcSEcCtD
Midodrine—Dry mouth—Epirubicin—stomach cancer	0.00116	0.00162	CcSEcCtD
Midodrine—Pruritus—Capecitabine—stomach cancer	0.00115	0.00161	CcSEcCtD
Midodrine—Confusional state—Epirubicin—stomach cancer	0.00114	0.0016	CcSEcCtD
Midodrine—Nervous system disorder—Epirubicin—stomach cancer	0.00111	0.00156	CcSEcCtD
Midodrine—Dizziness—Docetaxel—stomach cancer	0.00111	0.00156	CcSEcCtD
Midodrine—Hypertension—Doxorubicin—stomach cancer	0.00111	0.00156	CcSEcCtD
Midodrine—Tachycardia—Epirubicin—stomach cancer	0.00111	0.00155	CcSEcCtD
Midodrine—Skin disorder—Epirubicin—stomach cancer	0.0011	0.00154	CcSEcCtD
Midodrine—Insomnia—Methotrexate—stomach cancer	0.00109	0.00154	CcSEcCtD
Midodrine—Anxiety—Doxorubicin—stomach cancer	0.00109	0.00153	CcSEcCtD
Midodrine—Paraesthesia—Methotrexate—stomach cancer	0.00109	0.00153	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00109	0.00152	CcSEcCtD
Midodrine—Dyspnoea—Methotrexate—stomach cancer	0.00108	0.00151	CcSEcCtD
Midodrine—Somnolence—Methotrexate—stomach cancer	0.00108	0.00151	CcSEcCtD
Midodrine—Dizziness—Capecitabine—stomach cancer	0.00107	0.00151	CcSEcCtD
Midodrine—Dry mouth—Doxorubicin—stomach cancer	0.00107	0.0015	CcSEcCtD
Midodrine—Dyspepsia—Methotrexate—stomach cancer	0.00107	0.0015	CcSEcCtD
Midodrine—Rash—Docetaxel—stomach cancer	0.00106	0.00149	CcSEcCtD
Midodrine—Dermatitis—Docetaxel—stomach cancer	0.00106	0.00148	CcSEcCtD
Midodrine—Confusional state—Doxorubicin—stomach cancer	0.00106	0.00148	CcSEcCtD
Midodrine—Headache—Docetaxel—stomach cancer	0.00105	0.00148	CcSEcCtD
Midodrine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00104	0.00147	CcSEcCtD
Midodrine—Pain—Methotrexate—stomach cancer	0.00103	0.00145	CcSEcCtD
Midodrine—Nervous system disorder—Doxorubicin—stomach cancer	0.00103	0.00144	CcSEcCtD
Midodrine—Rash—Capecitabine—stomach cancer	0.00102	0.00144	CcSEcCtD
Midodrine—Insomnia—Epirubicin—stomach cancer	0.00102	0.00144	CcSEcCtD
Midodrine—Dermatitis—Capecitabine—stomach cancer	0.00102	0.00144	CcSEcCtD
Midodrine—Tachycardia—Doxorubicin—stomach cancer	0.00102	0.00144	CcSEcCtD
Midodrine—Headache—Capecitabine—stomach cancer	0.00102	0.00143	CcSEcCtD
Midodrine—Skin disorder—Doxorubicin—stomach cancer	0.00102	0.00143	CcSEcCtD
Midodrine—Paraesthesia—Epirubicin—stomach cancer	0.00102	0.00143	CcSEcCtD
Midodrine—Dyspnoea—Epirubicin—stomach cancer	0.00101	0.00142	CcSEcCtD
Midodrine—Somnolence—Epirubicin—stomach cancer	0.00101	0.00141	CcSEcCtD
Midodrine—Nausea—Docetaxel—stomach cancer	0.000997	0.0014	CcSEcCtD
Midodrine—Feeling abnormal—Methotrexate—stomach cancer	0.000997	0.0014	CcSEcCtD
Midodrine—Dyspepsia—Epirubicin—stomach cancer	0.000997	0.0014	CcSEcCtD
Midodrine—Gastrointestinal pain—Methotrexate—stomach cancer	0.00099	0.00139	CcSEcCtD
Midodrine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000978	0.00137	CcSEcCtD
Midodrine—Pain—Epirubicin—stomach cancer	0.000968	0.00136	CcSEcCtD
Midodrine—Nausea—Capecitabine—stomach cancer	0.000966	0.00136	CcSEcCtD
Midodrine—Abdominal pain—Methotrexate—stomach cancer	0.000957	0.00134	CcSEcCtD
Midodrine—Insomnia—Doxorubicin—stomach cancer	0.000948	0.00133	CcSEcCtD
Midodrine—Paraesthesia—Doxorubicin—stomach cancer	0.000941	0.00132	CcSEcCtD
Midodrine—Dyspnoea—Doxorubicin—stomach cancer	0.000934	0.00131	CcSEcCtD
Midodrine—Feeling abnormal—Epirubicin—stomach cancer	0.000933	0.00131	CcSEcCtD
Midodrine—Somnolence—Doxorubicin—stomach cancer	0.000932	0.00131	CcSEcCtD
Midodrine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000926	0.0013	CcSEcCtD
Midodrine—Dyspepsia—Doxorubicin—stomach cancer	0.000922	0.00129	CcSEcCtD
Midodrine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000905	0.00127	CcSEcCtD
Midodrine—Pain—Doxorubicin—stomach cancer	0.000896	0.00126	CcSEcCtD
Midodrine—Abdominal pain—Epirubicin—stomach cancer	0.000895	0.00126	CcSEcCtD
Midodrine—Asthenia—Methotrexate—stomach cancer	0.000868	0.00122	CcSEcCtD
Midodrine—Feeling abnormal—Doxorubicin—stomach cancer	0.000863	0.00121	CcSEcCtD
Midodrine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000857	0.0012	CcSEcCtD
Midodrine—Pruritus—Methotrexate—stomach cancer	0.000856	0.0012	CcSEcCtD
Midodrine—Abdominal pain—Doxorubicin—stomach cancer	0.000828	0.00116	CcSEcCtD
Midodrine—Asthenia—Epirubicin—stomach cancer	0.000813	0.00114	CcSEcCtD
Midodrine—Pruritus—Epirubicin—stomach cancer	0.000801	0.00112	CcSEcCtD
Midodrine—Dizziness—Methotrexate—stomach cancer	0.0008	0.00112	CcSEcCtD
Midodrine—Rash—Methotrexate—stomach cancer	0.000763	0.00107	CcSEcCtD
Midodrine—Dermatitis—Methotrexate—stomach cancer	0.000762	0.00107	CcSEcCtD
Midodrine—Headache—Methotrexate—stomach cancer	0.000758	0.00106	CcSEcCtD
Midodrine—Asthenia—Doxorubicin—stomach cancer	0.000752	0.00106	CcSEcCtD
Midodrine—Dizziness—Epirubicin—stomach cancer	0.000749	0.00105	CcSEcCtD
Midodrine—Pruritus—Doxorubicin—stomach cancer	0.000741	0.00104	CcSEcCtD
Midodrine—Nausea—Methotrexate—stomach cancer	0.000719	0.00101	CcSEcCtD
Midodrine—Rash—Epirubicin—stomach cancer	0.000714	0.001	CcSEcCtD
Midodrine—Dermatitis—Epirubicin—stomach cancer	0.000713	0.001	CcSEcCtD
Midodrine—Headache—Epirubicin—stomach cancer	0.000709	0.000996	CcSEcCtD
Midodrine—Dizziness—Doxorubicin—stomach cancer	0.000693	0.000973	CcSEcCtD
Midodrine—Nausea—Epirubicin—stomach cancer	0.000673	0.000944	CcSEcCtD
Midodrine—Rash—Doxorubicin—stomach cancer	0.000661	0.000927	CcSEcCtD
Midodrine—Dermatitis—Doxorubicin—stomach cancer	0.00066	0.000927	CcSEcCtD
Midodrine—Headache—Doxorubicin—stomach cancer	0.000656	0.000922	CcSEcCtD
Midodrine—Nausea—Doxorubicin—stomach cancer	0.000622	0.000874	CcSEcCtD
Midodrine—ADRA1A—Signaling by GPCR—ADRB1—stomach cancer	0.000149	0.000518	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.000147	0.000512	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HBEGF—stomach cancer	0.000147	0.000512	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.000147	0.000512	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RGS2—stomach cancer	0.000145	0.000505	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GAST—stomach cancer	0.000145	0.000505	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000144	0.0005	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—FBP1—stomach cancer	0.000143	0.000498	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NDUFA2—stomach cancer	0.000143	0.000498	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CA1—stomach cancer	0.000143	0.000498	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CKB—stomach cancer	0.000143	0.000498	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000143	0.000497	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000139	0.000484	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FGG—stomach cancer	0.000138	0.000479	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—ADRB2—stomach cancer	0.000136	0.000472	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PLIN2—stomach cancer	0.000135	0.000468	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FST—stomach cancer	0.000134	0.000465	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PPP2R1A—stomach cancer	0.000133	0.000463	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000133	0.000463	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—ADRB2—stomach cancer	0.000133	0.000462	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HSPB1—stomach cancer	0.000133	0.000461	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AGTR2—stomach cancer	0.000133	0.000461	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRKAA1—stomach cancer	0.000133	0.000461	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—F2R—stomach cancer	0.000131	0.000456	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—BMP2—stomach cancer	0.000131	0.000456	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CA2—stomach cancer	0.000131	0.000456	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HBEGF—stomach cancer	0.000131	0.000455	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKR1C3—stomach cancer	0.000129	0.000448	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GAST—stomach cancer	0.000129	0.000448	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RGS2—stomach cancer	0.000129	0.000448	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RBP4—stomach cancer	0.000128	0.000445	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CXCL8—stomach cancer	0.000128	0.000445	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000128	0.000444	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NT5E—stomach cancer	0.000128	0.000444	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PGAM1—stomach cancer	0.000128	0.000444	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HTR1A—stomach cancer	0.000128	0.000444	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000127	0.000443	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—PRKCB—stomach cancer	0.000124	0.00043	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ANXA1—stomach cancer	0.000123	0.000429	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FGG—stomach cancer	0.000122	0.000425	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALDH7A1—stomach cancer	0.000122	0.000424	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PLCE1—stomach cancer	0.000122	0.000424	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—ADRB2—stomach cancer	0.000121	0.00042	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADRB1—stomach cancer	0.000119	0.000415	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PPP2R1A—stomach cancer	0.000118	0.000411	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000118	0.000411	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKAA1—stomach cancer	0.000118	0.000409	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—UMPS—stomach cancer	0.000117	0.000406	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RPS6—stomach cancer	0.000114	0.000396	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RBP4—stomach cancer	0.000114	0.000395	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CXCL8—stomach cancer	0.000114	0.000395	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000113	0.000393	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PRKCB—stomach cancer	0.000112	0.00039	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6ST—stomach cancer	0.000112	0.000389	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AGTR2—stomach cancer	0.00011	0.000383	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HSPB1—stomach cancer	0.00011	0.000383	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—F2R—stomach cancer	0.000109	0.000378	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—BMP2—stomach cancer	0.000109	0.000378	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PDHA1—stomach cancer	0.000109	0.000378	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ECHS1—stomach cancer	0.000109	0.000378	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKR1C3—stomach cancer	0.000107	0.000372	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR1A—stomach cancer	0.000106	0.000368	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HBEGF—stomach cancer	0.000105	0.000364	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PRKCB—stomach cancer	0.000103	0.000357	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ANXA1—stomach cancer	0.000102	0.000356	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—TYMP—stomach cancer	0.000102	0.000355	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—FADS1—stomach cancer	0.000102	0.000355	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6R—stomach cancer	9.97e-05	0.000347	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—RHOA—stomach cancer	9.92e-05	0.000345	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADRB1—stomach cancer	9.91e-05	0.000344	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HSPB1—stomach cancer	9.77e-05	0.00034	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AGTR2—stomach cancer	9.77e-05	0.00034	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADRB2—stomach cancer	9.67e-05	0.000336	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—F2R—stomach cancer	9.66e-05	0.000336	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—BMP2—stomach cancer	9.66e-05	0.000336	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SREBF2—stomach cancer	9.56e-05	0.000332	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKR1C3—stomach cancer	9.51e-05	0.000331	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PPP2R1A—stomach cancer	9.48e-05	0.00033	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RPS6—stomach cancer	9.47e-05	0.000329	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—RORA—stomach cancer	9.45e-05	0.000328	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR1A—stomach cancer	9.41e-05	0.000327	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PRKCB—stomach cancer	9.31e-05	0.000324	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6ST—stomach cancer	9.28e-05	0.000322	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PRKCB—stomach cancer	9.11e-05	0.000317	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ANXA1—stomach cancer	9.09e-05	0.000316	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—RHOA—stomach cancer	9.01e-05	0.000313	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALDOB—stomach cancer	8.85e-05	0.000308	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SMAD4—stomach cancer	8.8e-05	0.000306	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRB1—stomach cancer	8.8e-05	0.000306	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CXCL8—stomach cancer	8.71e-05	0.000303	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HBEGF—stomach cancer	8.7e-05	0.000302	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RPS6—stomach cancer	8.41e-05	0.000292	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FYN—stomach cancer	8.36e-05	0.00029	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6R—stomach cancer	8.28e-05	0.000288	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PRKCB—stomach cancer	8.27e-05	0.000288	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6ST—stomach cancer	8.24e-05	0.000286	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—RHOA—stomach cancer	8.23e-05	0.000286	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALOX5—stomach cancer	8.23e-05	0.000286	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—DPYD—stomach cancer	8.1e-05	0.000281	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADRB2—stomach cancer	8.03e-05	0.000279	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CXCL8—stomach cancer	7.91e-05	0.000275	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PPP2R1A—stomach cancer	7.87e-05	0.000273	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FGFR2—stomach cancer	7.84e-05	0.000273	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HBEGF—stomach cancer	7.73e-05	0.000269	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—RHOA—stomach cancer	7.48e-05	0.00026	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6R—stomach cancer	7.35e-05	0.000256	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—RHOA—stomach cancer	7.31e-05	0.000254	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SMAD4—stomach cancer	7.3e-05	0.000254	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CXCL8—stomach cancer	7.23e-05	0.000251	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IRS2—stomach cancer	7.18e-05	0.00025	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTT1—stomach cancer	7.16e-05	0.000249	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRB2—stomach cancer	7.13e-05	0.000248	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP2A6—stomach cancer	7.08e-05	0.000246	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PPP2R1A—stomach cancer	6.99e-05	0.000243	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CAV1—stomach cancer	6.96e-05	0.000242	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOA1—stomach cancer	6.95e-05	0.000242	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FYN—stomach cancer	6.94e-05	0.000241	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AKR1C3—stomach cancer	6.88e-05	0.000239	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ENO1—stomach cancer	6.71e-05	0.000233	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—RHOA—stomach cancer	6.64e-05	0.000231	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PRKCB—stomach cancer	6.63e-05	0.00023	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6ST—stomach cancer	6.6e-05	0.00023	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CXCL8—stomach cancer	6.56e-05	0.000228	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FGFR2—stomach cancer	6.51e-05	0.000226	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SMAD4—stomach cancer	6.49e-05	0.000226	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CXCL8—stomach cancer	6.42e-05	0.000223	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APC—stomach cancer	6.34e-05	0.000221	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FYN—stomach cancer	6.16e-05	0.000214	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—MAPK3—stomach cancer	6.08e-05	0.000211	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IRS2—stomach cancer	5.96e-05	0.000207	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CD44—stomach cancer	5.95e-05	0.000207	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6R—stomach cancer	5.89e-05	0.000205	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CXCL8—stomach cancer	5.83e-05	0.000203	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FGFR2—stomach cancer	5.78e-05	0.000201	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—MAPK1—stomach cancer	5.78e-05	0.000201	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CAV1—stomach cancer	5.78e-05	0.000201	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—EGFR—stomach cancer	5.78e-05	0.000201	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOA1—stomach cancer	5.77e-05	0.000201	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—PIK3CA—stomach cancer	5.52e-05	0.000192	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SERPINE1—stomach cancer	5.52e-05	0.000192	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRKCB—stomach cancer	5.5e-05	0.000191	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6ST—stomach cancer	5.48e-05	0.000191	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—KRAS—stomach cancer	5.46e-05	0.00019	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RHOA—stomach cancer	5.32e-05	0.000185	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IRS2—stomach cancer	5.3e-05	0.000184	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NOS3—stomach cancer	5.27e-05	0.000183	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APC—stomach cancer	5.27e-05	0.000183	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CAV1—stomach cancer	5.13e-05	0.000179	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOA1—stomach cancer	5.12e-05	0.000178	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	5.06e-05	0.000176	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—MAPK3—stomach cancer	5.04e-05	0.000175	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PIK3CA—stomach cancer	5.02e-05	0.000174	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTP1—stomach cancer	4.96e-05	0.000173	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ERBB2—stomach cancer	4.93e-05	0.000171	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HMOX1—stomach cancer	4.89e-05	0.00017	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6R—stomach cancer	4.89e-05	0.00017	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	4.89e-05	0.00017	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	4.87e-05	0.000169	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—MAPK1—stomach cancer	4.8e-05	0.000167	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—EGFR—stomach cancer	4.8e-05	0.000167	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APC—stomach cancer	4.68e-05	0.000163	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCL8—stomach cancer	4.67e-05	0.000162	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—HRAS—stomach cancer	4.64e-05	0.000161	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—TYMS—stomach cancer	4.61e-05	0.00016	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PIK3CA—stomach cancer	4.58e-05	0.000159	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SERPINE1—stomach cancer	4.58e-05	0.000159	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CDKN1B—stomach cancer	4.56e-05	0.000159	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTM1—stomach cancer	4.56e-05	0.000159	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—KRAS—stomach cancer	4.53e-05	0.000158	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	4.48e-05	0.000156	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6—stomach cancer	4.44e-05	0.000154	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RHOA—stomach cancer	4.42e-05	0.000154	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NOS3—stomach cancer	4.37e-05	0.000152	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCND1—stomach cancer	4.35e-05	0.000151	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6R—stomach cancer	4.34e-05	0.000151	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—JUN—stomach cancer	4.34e-05	0.000151	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ERCC2—stomach cancer	4.29e-05	0.000149	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	4.26e-05	0.000148	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	4.26e-05	0.000148	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MMP9—stomach cancer	4.23e-05	0.000147	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CDKN1A—stomach cancer	4.21e-05	0.000146	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PIK3CA—stomach cancer	4.16e-05	0.000145	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAPK8—stomach cancer	4.11e-05	0.000143	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ERBB2—stomach cancer	4.09e-05	0.000142	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	4.07e-05	0.000142	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	4.07e-05	0.000141	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—MTHFR—stomach cancer	4.03e-05	0.00014	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	4.03e-05	0.00014	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RHOA—stomach cancer	3.92e-05	0.000136	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NOS3—stomach cancer	3.88e-05	0.000135	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCL8—stomach cancer	3.88e-05	0.000135	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HRAS—stomach cancer	3.85e-05	0.000134	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—VEGFA—stomach cancer	3.79e-05	0.000132	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	3.79e-05	0.000132	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—STAT3—stomach cancer	3.76e-05	0.000131	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CAV1—stomach cancer	3.72e-05	0.000129	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOA1—stomach cancer	3.71e-05	0.000129	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	3.7e-05	0.000129	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6—stomach cancer	3.69e-05	0.000128	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	3.63e-05	0.000126	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCND1—stomach cancer	3.61e-05	0.000126	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—JUN—stomach cancer	3.6e-05	0.000125	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	3.59e-05	0.000125	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MMP9—stomach cancer	3.51e-05	0.000122	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	3.49e-05	0.000121	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MYC—stomach cancer	3.49e-05	0.000121	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	3.44e-05	0.00012	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	3.42e-05	0.000119	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	3.41e-05	0.000119	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—EGFR—stomach cancer	3.41e-05	0.000119	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	3.41e-05	0.000119	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	3.36e-05	0.000117	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6—stomach cancer	3.27e-05	0.000114	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARG—stomach cancer	3.27e-05	0.000114	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—KRAS—stomach cancer	3.23e-05	0.000112	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCND1—stomach cancer	3.21e-05	0.000112	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—JUN—stomach cancer	3.2e-05	0.000111	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	3.15e-05	0.000109	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—STAT3—stomach cancer	3.12e-05	0.000108	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MMP9—stomach cancer	3.11e-05	0.000108	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	3.1e-05	0.000108	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	3.03e-05	0.000105	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	2.98e-05	0.000104	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	2.96e-05	0.000103	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALB—stomach cancer	2.94e-05	0.000102	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MYC—stomach cancer	2.9e-05	0.000101	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TP53—stomach cancer	2.87e-05	9.97e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	2.83e-05	9.85e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EGFR—stomach cancer	2.83e-05	9.85e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NOS3—stomach cancer	2.81e-05	9.77e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	2.8e-05	9.72e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—STAT3—stomach cancer	2.77e-05	9.63e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HRAS—stomach cancer	2.74e-05	9.53e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—KRAS—stomach cancer	2.68e-05	9.31e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	2.65e-05	9.2e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6—stomach cancer	2.62e-05	9.12e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MYC—stomach cancer	2.57e-05	8.95e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTGS2—stomach cancer	2.57e-05	8.94e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	2.52e-05	8.75e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EGFR—stomach cancer	2.52e-05	8.75e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	2.46e-05	8.55e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TP53—stomach cancer	2.38e-05	8.27e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—KRAS—stomach cancer	2.38e-05	8.27e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HRAS—stomach cancer	2.28e-05	7.91e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	2.18e-05	7.59e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6—stomach cancer	2.18e-05	7.57e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TP53—stomach cancer	2.11e-05	7.35e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HRAS—stomach cancer	2.02e-05	7.03e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6—stomach cancer	1.93e-05	6.73e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.58e-05	5.5e-05	CbGpPWpGaD
